This is a pivotal time for policymakers to be vigilant about drug shortages and to ensure that Canadians have reliable access to safe drugs.
Academic rigor, journalistic flair
Articles on Drug makers
Displaying all articles
In the 1980s, CSIRO and its university collaborators set into motion a chain of events that would lead to the production of relenza, the first drug to successfully treat the flu.
Politicians and even HHS are now discussing ways to allow US consumers to buy drugs from Canada. Here’s why it’s not as simple as it seems.
Top contributors
-
Professor of Innovation Studies, Swinburne University of Technology
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor, Faculty of Law and Cumming School of Medicine; Member, AMR One Health Consortium, University of Calgary
-
Visiting Fellow, Swinburne University of Technology
-
Assistant Professor, Community Health Sciences, Cumming School of Medicine, University of Calgary
